Preoperative Chemotherapy of Colorectal Liver Metastases_CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY

Authors：

邢宝才 ¹ , 丁兆武 ²

Corresponding author：

Keywords：

结直肠癌; 肝转移; 术前化疗

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Citation： 邢宝才,丁兆武. Preoperative Chemotherapy of Colorectal Liver Metastases. CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY, 2011, 18(5): 473-474. doi: Copy

1.	Benoist S, Nordlinger B. The role of preoperative chemotherapy in patients with resectable colorectal liver metastases [J]. Ann Surg Oncol, 2009, 16(9): 23852390.
2.	Kemeny N. The management of resectable and unresectable liver metastases from colorectal cancer [J]. Curr Opin Oncol， 2010， 22（4）: 364373.
3.	Kopetz S, Chang GJ, Overman MJ, et al. Improved survival in metastatic colorectal cancer is associated with adoption of hepatic resection and improved chemotherapy [J]. J Clin Oncol, 2009， 27(22): 36773683.
4.	Gallagher D, Kemeny N. Metastatic colorectal cancer: from improved survival to potential cure [J]. Oncology, 2010， 78（34）: 237248.
5.	Choti M. Controversies in the management of hepatic colorectal metastases [J]. Ann Surg Oncol， 2009， 16（9）: 23832384.
6.	Kishi Y, Zorzi D, Contreras CM, et al. Extended preoperative chemotherapy does not improve pathologic response and increase postoperative liver insufficiency after hepatic resection for colorectal liver metastases [J]. Ann Surg Oncol， 2010， 17（11）: 28702876.
7.	Adam R, Haller DG, Poston G, et al. Toward optimized frontline therapeutic strategies in patients with metastatic colorectal cancer—an expert review from the international congress on anticancer treatment (ICACT) 2009 [J]. Ann Oncol， 2009, 21(8): 15791584.
8.	Nordlinger B, Cutsem E, Greuenberger B, et al. Combination of surgery and chemotherapy and the role of targeted agents in the treatment of patients with colorectal liver metastases: recommendations from an expert panel [J]. Ann Oncol, 2009, 20(6): 985992.
9.	Van Cutsem E, Kohne C, Hitre E, et al. Cetuximab and chemotherapy as initial treatment for metastatic colorectal cancer [J]. N Engl J Med, 2009, 360(14): 14081417.
10.	Bokemeyer C, Bondarenko I, Makhson A, et al. Fluorouracil, leucovorin, and oxaliplatin with and without cetuximab in the firstline treatment of metastatic colorectal cancer [J]. J Clin Oncol, 2009, 27(5): 663671.
11.	Folprecht G, Gruenberger T, Bechstein WO, et al. Tumour response and secondary resectability of colorectal liver metastases following neoadjuvant chemotherapy with cetuximab: the CELIM randomised phase 2 trial [J]. Lancet Oncol, 2010, 11(1): 3847.
12.	Okines A, Del Puerto O, Cunningham D, et al. Surgery with curativeintent in patients treated with firstline chemotherapy plus bevacizumab for metastatic colorectal cancer First BEAT and the randomised phaseⅢ NO16966 trial [J]. Br J Cancer, 2009, 101(7): 10331038.

1. Benoist S, Nordlinger B. The role of preoperative chemotherapy in patients with resectable colorectal liver metastases [J]. Ann Surg Oncol, 2009, 16(9): 23852390.
2. Kemeny N. The management of resectable and unresectable liver metastases from colorectal cancer [J]. Curr Opin Oncol， 2010， 22（4）: 364373.
3. Kopetz S, Chang GJ, Overman MJ, et al. Improved survival in metastatic colorectal cancer is associated with adoption of hepatic resection and improved chemotherapy [J]. J Clin Oncol, 2009， 27(22): 36773683.
4. Gallagher D, Kemeny N. Metastatic colorectal cancer: from improved survival to potential cure [J]. Oncology, 2010， 78（34）: 237248.
5. Choti M. Controversies in the management of hepatic colorectal metastases [J]. Ann Surg Oncol， 2009， 16（9）: 23832384.
6. Kishi Y, Zorzi D, Contreras CM, et al. Extended preoperative chemotherapy does not improve pathologic response and increase postoperative liver insufficiency after hepatic resection for colorectal liver metastases [J]. Ann Surg Oncol， 2010， 17（11）: 28702876.
7. Adam R, Haller DG, Poston G, et al. Toward optimized frontline therapeutic strategies in patients with metastatic colorectal cancer—an expert review from the international congress on anticancer treatment (ICACT) 2009 [J]. Ann Oncol， 2009, 21(8): 15791584.
8. Nordlinger B, Cutsem E, Greuenberger B, et al. Combination of surgery and chemotherapy and the role of targeted agents in the treatment of patients with colorectal liver metastases: recommendations from an expert panel [J]. Ann Oncol, 2009, 20(6): 985992.
9. Van Cutsem E, Kohne C, Hitre E, et al. Cetuximab and chemotherapy as initial treatment for metastatic colorectal cancer [J]. N Engl J Med, 2009, 360(14): 14081417.
10. Bokemeyer C, Bondarenko I, Makhson A, et al. Fluorouracil, leucovorin, and oxaliplatin with and without cetuximab in the firstline treatment of metastatic colorectal cancer [J]. J Clin Oncol, 2009, 27(5): 663671.
11. Folprecht G, Gruenberger T, Bechstein WO, et al. Tumour response and secondary resectability of colorectal liver metastases following neoadjuvant chemotherapy with cetuximab: the CELIM randomised phase 2 trial [J]. Lancet Oncol, 2010, 11(1): 3847.
12. Okines A, Del Puerto O, Cunningham D, et al. Surgery with curativeintent in patients treated with firstline chemotherapy plus bevacizumab for metastatic colorectal cancer First BEAT and the randomised phaseⅢ NO16966 trial [J]. Br J Cancer, 2009, 101(7): 10331038.

CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY

Preoperative Chemotherapy of Colorectal Liver Metastases

Abstract Full text Figures/Tables Video References Cited by

Format

Content